Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Avidity Partners Management LP | 2,189,719 9.900% |
69,719 (+3.29%) |
Filing History |
| 2023-02-14 06:15 am Purchase |
2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Bain Capital Life Sciences Fund II, L.P. | 2,124,694 11.000% |
2,124,694 (New Position) |
Filing History |
| 2023-02-10 7:41 pm Purchase |
2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Artal Participations S.a r.l | 1,463,829 7.200% |
1,113,829 (+318.24%) |
Filing History |
| 2023-01-27 6:01 pm Purchase |
2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Ally Bridge MedAlpha Master Fund L.P. | 1,439,379 6.900% |
1,439,379 (New Position) |
Filing History |
| 2023-01-25 5:00 pm Purchase |
2023-01-15 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ADAGE CAPITAL PARTNERS GP LLC | 1,253,828 6.040% |
1,253,828 (New Position) |
Filing History |
| 2022-11-10 11:55 am Purchase |
2022-11-09 | 13G | Syros Pharmaceuticals, Inc. SYRS |
FMR CORP | 104,614 0.516% |
104,614 (New Position) |
Filing History |
| 2022-09-20 4:35 pm Purchase |
2022-09-16 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Avidity Partners Management LP | 2,120,000 9.900% |
2,120,000 (New Position) |
Filing History |
| 2022-09-19 4:07 pm Purchase |
2022-09-16 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Deep Track Capital, LP | 699,281 9.990% |
699,281 (New Position) |
Filing History |
| 2022-09-16 4:31 pm Sale |
2022-09-15 | 13D | Flexible Solutions International, Inc. FSI |
TYME TECHNOLOGIES INC. TYME |
0 0.000% |
-17,460,552 (Position Closed) |
Filing History |
| 2022-07-13 5:15 pm Purchase |
2022-07-03 | 13D | Flexible Solutions International, Inc. FSI |
TYME TECHNOLOGIES INC. TYME |
17,460,552 28.000% |
17,460,552 (New Position) |
Filing History |
| 2022-07-13 5:10 pm Purchase |
2022-07-03 | 13D | Flexible Solutions International, Inc. FSI |
Syros Pharmaceuticals Inc. SYRS |
17,819,723 9.900% |
17,819,723 (New Position) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Syros Pharmaceuticals, Inc. SYRS |
BLACKROCK INC BLK |
152,431 2.400% |
-270,796 (-63.98%) |
Filing History |
| 2022-04-11 09:01 am Sale |
2022-04-08 | 13G | Syros Pharmaceuticals, Inc. SYRS |
FMR CORP | 579,788 9.298% |
-353,492 (-37.88%) |
Filing History |
| 2022-02-14 06:41 am Purchase |
2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Bain Capital Life Sciences Fund II, L.P. | 626,442 11.000% |
47,938 (+8.29%) |
Filing History |
| 2022-02-14 06:06 am Sale |
2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Nikko Asset Management Americas, Inc. | 0 0.000% |
-438,199 (Position Closed) |
Filing History |
| 2022-02-11 4:17 pm Purchase |
2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Ally Bridge MedAlpha Master Fund L.P. | 393,052 6.300% |
89,740 (+29.59%) |
Filing History |
| 2022-02-11 06:28 am Purchase |
2022-02-02 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Artal Participations S.a r.l | 350,000 5.600% |
350,000 (New Position) |
Filing History |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Syros Pharmaceuticals, Inc. SYRS |
FMR CORP | 933,280 14.999% |
242,046 (+35.02%) |
Filing History |
| 2022-02-04 06:09 am Sale |
2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Sumitomo Mitsui Trust Group, Inc. | 0 0.000% |
-438,199 (Position Closed) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
BLACKROCK INC BLK |
423,227 6.800% |
90,671 (+27.26%) |
Filing History |